Levetimide

• UNSPSC Description:

  Levetimide is a potent and stereoselective inhibitor of [3H](+)pentazocine binding, with a Ki of 2.2 nM[1].

• Target Antigen:

  mAChR

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/levetimide.html

• Purity:

  99.96

• Solubility:

  DMSO : ≥ 100 mg/mL

• Smiles:

  O=C(N1)[C@](C2=CC=CC=C2)(CCC1=O)C3CCN(CC3)CC4=CC=CC=C4

• Molecular Weight:

  362.46

• References & Citations:

  [1]DeHaven-Hudkins DL, et al. Binding of dexetimide and levetimide to [3H](+)pentazocine- and [3H]1,3-di(2-tolyl)guanidine-defined sigma recognition sites. Life Sci. 1991;49(18):PL135-9.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  21888-99-3